Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

First-Inventor-to-file: Protect Your Research Data

pharma-iq.com — Wed, 23 May 2012 04:00:00 GMT

Join in Live May 23 from 10.00-11.00 AM EST ¦ 3.00-4.00pm UK Time The Agilent OpenLAB ELN is used by global R&D labs that need to protect their Intellectual Property. Electronic records are increasingly being used to support patent information and filing. Therefore, they

hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing

pharma-iq.com — Wed, 28 Mar 2012 04:00:00 GMT

This presentation demonstrates how hESC derived cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas describes how hESC derived Cytiva Cardiomyocytes: are a valid model of cardiomyocytes from the human heart are compatible with assays routinely

Breakthroughs in CRO Customer Service

pharma-iq.com — Thu, 23 Feb 2012 05:00:00 GMT

The Agilent OpenLAB ELN is used by global R&D labs that include Contract Research Organizations (CROs) to pharmaceutical development and academic research institutions. While many CROs specifically provide clinical-study and clinical-trial support for drugs and/or medical devices,

EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches

pharma-iq.com — Thu, 09 Feb 2012 05:00:00 GMT

Launching your drug product onto the European Market can present a real challenge if you are not familiar with country specific requirements, particularly if you are based in the U.S. With its 27 member states, numerous official working languages and complex regulatory framework, this

The Changing Face of Sample Management

pharma-iq.com — Wed, 25 Jan 2012 05:00:00 GMT

This webinar will focus on: Reducing your facility’s footprint for leaner operation Focusing on new areas within compound management New areas they’re working on that they weren’t covering before Creating goals for the future and acting upon changes currently in

From Produce to Patients: Improving Efficiency, Accountability and Accessibility Through Use of GS1 Standards

pharma-iq.com — Wed, 18 Jan 2012 05:00:00 GMT

This webinar will cover: Applying GS1 bar code and RFID technology within the healthcare industry to track devices and processes to save costs and time (and avoid serious adverse effects) Utilising unique identifiers in compliance with regulations and complimentary healthcare

Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys

pharma-iq.com — Fri, 13 Jan 2012 05:00:00 GMT

Results of a recent industry wide survey show that biopharmaceutical companies are planning to make a gradual increase in investment in new, predictive safety technologies. While 53% of respondents say their organization’s spending levels will remain “about the same,”

Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security

pharma-iq.com — Tue, 13 Dec 2011 05:00:00 GMT

Serialization as part of the battle on counterfeit drugs and supply chain security has been established in various ways over the last decade – at different levels of success for the industry investing in such measures. With legislation becoming effective in an increasing number of

Increasing Laboratory Efficiency and Reducing Reporting Times: An Innovative Approach to Creating an All-In-One Informatics Platform

pharma-iq.com — Thu, 01 Dec 2011 05:00:00 GMT

The world premiere of Ensemble: the integrated result of four informatics businesses From R&D to biology and QA: how to deal with disparate data types and processes using a single platform A selection of implementation case studies: practical examples highlighting real-world

Expanding the Reach of the ELN to Drive Better, Faster Decisions

pharma-iq.com — Wed, 23 Nov 2011 05:00:00 GMT

This webinar will cover: Connecting scientists, information, tasks and instruments Changing the way scientists capture, process and use information and knowledge Providing a single collaborative environment for data analysis and decision making Delivering advanced data storage and

Distinguishing Between ELNs and LIMS

pharma-iq.com — Mon, 21 Nov 2011 05:00:00 GMT

This webinar will cover: Understanding the common definitions of LIMS and ELNs Identifying where system functionalities overlap and differ Following the development of each system and predicting their future trajectories

Overcoming Common Lyophilization Scale-up Issues

pharma-iq.com — Tue, 15 Nov 2011 05:00:00 GMT

Topics covered in this seminar - Characterizing your systems (apparatus, containers, product) with a limited number of experiments and a simple procedure - Utilizing advanced monitoring tools to speed up the system characterisation process - Examining safe process

Developing a Single Product for Multiple Markets

pharma-iq.com — Tue, 25 Oct 2011 04:00:00 GMT

Meeting the manufacturing requirements of FDA, EMEA and TGA is a common challenge for those undertaking product development in the context of multicentre studies. When optimising a product to ensure its commercial viability what can be done to pre-empt likely concerns of multiple

Improving Sample Management QC and Reducing Costs by Regular Sample Auditing

pharma-iq.com — Wed, 05 Oct 2011 04:00:00 GMT

Data indicates that many organisations experience sample precipitation from around 5 to 6% of their samples; studies have shown this may rise to greater than 12% for newly acquired samples. Other work indicates that around 5% of tubes in a typical storage facility are actually empty, and

Taking a Comparative Approach to the Cost and Performance Analysis of Single-Use TFF Technology

pharma-iq.com — Thu, 29 Sep 2011 04:00:00 GMT

Single use filtration technology is an advancing field, this webinar takes you through a direct comparison of single use and fixed TFF approaches. You will gain the tools to assess where and when to implement each system in your own process design and understand when single

NORD and EURORDIS: Uniting Communities through Social Media

pharma-iq.com — Tue, 13 Sep 2011 04:00:00 GMT

Patients in the rare disease community often feel isolated. Support systems such as patient organizations and online communities are integral in helping to diminish those feelings. Discuss how rare diseases are increasingly being recognized as an international public health challenge,

Social Media & Pharma: New Frontier or Wild West?

pharma-iq.com — Mon, 12 Sep 2011 04:00:00 GMT

About this webinar: FDA guidance will provide little guidance: what to do when expected regulatory emancipation does not materialize Understanding how fear of adverse event discovery may be a blessing in disguise It’s content not platform that counts The specter of sponsorship

Biomarkers in Drug Discovery and Development

pharma-iq.com — Tue, 06 Sep 2011 04:00:00 GMT

About this webinar : Biomarkers have been defined as characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes and pharmacologic responses to therapeutic intervention. In drug discovery and development, biomarkers carry

Biobanking Challenges under the Microscope: Ethics and Harmonisation

pharma-iq.com — Wed, 03 Aug 2011 04:00:00 GMT

This webinar looks at ethical considerations and harmonisation challenges for biobanking on a global level. We open with a presentation from Nik Zeps on ethics addressing consent, data sharing, benefit sharing and protection of participants. Nik discusses human biospecimens in research

Outsourcing: Challenging the Project Management System at Your Organisation

pharma-iq.com — Tue, 19 Jul 2011 04:00:00 GMT

Join Jubilant HollisterStier Senior Manager, William Allen, as he evaluates what to consider when reviewing the project management capabilities of your current CMO, potential CMO, and the internal PMO system at your organisation. Mr. Allen will review successful outsourcing parameters,